- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/21 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Pseudomonadaceae (F)
Patent holdings for IPC class C07K 14/21
Total number of patents in this class: 543
10-year publication summary
|
45
|
38
|
55
|
40
|
48
|
43
|
31
|
32
|
30
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6627 |
46 |
| Glaxosmithkline Biologicals S.A. | 1650 |
36 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
22 |
| Aridis Pharmaceuticals Inc. | 26 |
10 |
| University of Maryland, Baltimore | 1027 |
9 |
| The Board of Trustees of the University of Illinois | 2713 |
8 |
| The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 168 |
8 |
| Wake Forest University Health Sciences | 723 |
7 |
| President and Fellows of Harvard College | 5995 |
6 |
| Spogen Biotech Inc. | 137 |
6 |
| Plant Health Care, Inc. | 60 |
5 |
| Viventia Bio Inc. | 22 |
5 |
| Applied Molecular Transport Inc. | 18 |
5 |
| Evonik Operations GmbH | 4154 |
5 |
| Corteva Agriscience LLC | 2694 |
5 |
| Evaxion Biotech A/S | 54 |
5 |
| BASF SE | 20979 |
4 |
| E. I. du Pont de Nemours and Company | 4012 |
4 |
| Janssen Pharmaceuticals, Inc. | 436 |
4 |
| Evonik Degussa GmbH | 1493 |
4 |
| Other owners | 339 |